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Abstract:
OBJECTIVE: Obstructive sleep apnea syndrome (OSAS) is an episodic disease that is characterized 
by intermittent partial interruption of breathing during sleep, which results in low oxygen levels in 
organs and tissues. The characteristic symptoms of OSAS include snoring, apnea or hypopnea, and 
excessive daytime sleepiness. Our aim is to determine the early diagnosis of diabetes and to initiate 
treatments for OSAS patients according to the results of polysomnography (PSG) in the sleep polyclinic 
based on fasting blood glucose and HbA1c levels in patients with known OSAS without diabetes.
MATERIALS AND METHODS: Patients who applied to the sleep polyclinic of the Pamukkale 
University and were diagnosed with OSAS using PSG were included in the study.
RESULTS: A total of 44 patients with OSAS and a control group consisting of 47 people meeting 
these criteria were included. Compared with the control group, the patient groups showed significantly 
higher Hb values (P < 0.05) and lower mean corpuscular volume (P < 0.05). Significant negative 
correlations were found between glucose levels and mean O2 saturation values in patients with 
severe OSAS (apnea–hypopnea index > 30) (r = −0.583, P = 0.02).
CONCLUSION: In conclusion, even though significant differences were not found in the glucose 
and HbA1c levels of patients with OSAS, glucose metabolism was deteriorated when saturation was 
decreased in severe OSAS. Therefore, glucose levels should be observed frequently, particularly 
in severe cases of OSAS or in patients with hypoxia, regardless of the stage. More attention should 
also be paid to the development of diabetes.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is an episodic disease that 
is characterized by intermittent partial 
interruption of breathing during sleep, 
which results in low oxygen levels in 
organs and tissues.[1] The characteristic 
symptoms of OSAS include snoring, apnea 
or hypopnea, and excessive daytime 
sleepiness.[2] OSAS occurs in approximately 
3%–7% of males and 2%–5% of females in 
the general population and is a significant 
cause of mortality and morbidity.[3] OSAS 
is diagnosed and classified according 
to the apnea–hypopnea index (AHI) in 
polysomnography (PSG). AHI >5 indicates 
OSAS, with AHI of 5–15 indicating mild, 
15–30 indicating moderate, and over 30 
indicating severe OSAS.[4]
Changes in oxygen saturation and frequent 
awakening episodes in OSAS can also 
Address for 
correspondence: 
Dr. Erhan Ugurlu, 
Department of Chest 
Diseases, Pamukkale 
University, Denizli, Turkey. 
E-mail: drerhanugurlu@
gmail.com
Departments of Chest 
Diseases, 1Endocrinology 
and 2Internal Medicine, 
Pamukkale University, 
Denizli, Turkey
Original Article
Access this article online
Quick Response Code:
Website:
***
DOI:
10.4103/ejop.ejop_11_18
How to cite this article: Ugurlu E, Can I, Ertürk MS, 
Akbudak IH, Dursunoglu N, Ozkurt S. Relationship 
between hematological examination, glucose, HbA1c 
level, and disease stages in patients with obstructive 
sleep apnea syndrome. Eurasian J Pulmonol 
2018;20:33-36.
This is an open access journal,  and articles are 
distributed under the terms of the Creative Commons 
Attribution‑NonCommercial‑ShareAlike 4.0 License, which 
allows others to remix, tweak, and build upon the work 
non-commercially, as long as appropriate credit is given and 
the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
Ugurlu, et al.: Relationship between diabetes mellitus with OSAS
34 Eurasian Journal of Pulmonology - Volume 20, Issue 1, January-April 2018
damage respiratory, cardiac, metabolic, and cognitive 
functions.[5] High hypoxemia and elevated AHI cause 
dysfunction of the pancreatic beta cells.[6] In previous 
studies, fasting blood sugar and HbA1c elevation were 
detected in patients with OSAS. However, the number 
of studies comparing the hematological parameters 
and glucose, HbA1c values with OSAS stages is 
limited. Fasting blood sugar and HbA1c elevation cause 
atherosclerosis and can lead to cardiovascular diseases.[7]
Our aim is to determine the early diagnosis of diabetes 
and to initiate treatments for OSAS patients according 
to the results of PSG in the sleep polyclinic based on 
fasting blood sugar and HbA1c levels in patients with 
known OSAS without diabetes. We also compare fasting 
blood sugar and HbA1c levels according to the OSAS 
stages and to detect whether the stages are linked with 
diabetes mellitus. We also aimed to study whether there 
is a relationship between OSAS disease and other blood 
parameters.
Materials and Methods
Study population
Ethical approval was obtained from the University 
Ethical Board on Human Experiments (approval number 
60116787‑020/54962). All participants gave their written 
informed consent to the study. The patients, who had 
been diagnosed with OSAS by PSG after referring to the 
sleep clinic of the university with one or more complaints 
such as snoring, witnessed apnea, and excessive daytime 
sleepiness were taken to the study. Patients were not 
included in the study if they had a history of smoking, 
a previous diagnosis of diabetes, serious heart disease 
(congestive heart failure, valvular heart disease, etc.), 
other known lung disease (chronic obstructive pulmonary 
disease, asthma, interstitial lung disease, lung cancer, etc.), 
or other chronic diseases (hematological diseases, 
kidney, and liver diseases). These OSAS patients 
were divided into mild, moderate, and severe groups 
according to AHI. Healthy control group was composed 
of nonsmoker healthy persons who had no illnesses or 
no sleeping problems (apnea, snoring, excessive daytime 
sleepiness, insomnia, etc.), that came only for control 
purposes to the internal medicine clinic. Hemograms, 
fasting blood sugar, and HbA1c levels were evaluated 
in both groups.
Polysomnography
The examination was made in a single, quiet, dark, 
heat‑controlled room with Philips Respironics alice 
6 LDxS sleeping devices. Electroencephalography, 
electro‑oculography, chin electromyography, oral and 
nasal airflow measurements (nasal‑oral “thermistor” 
and nasal cannulae) were performed. Thorax and 
abdominal movements were evaluated. Arterial oxygen 
saturation (with pulse oximeter) and ECG recordings 
were taken. All records were evaluated by a chest 
physician specializing in sleep. A hypopnea was defined 
as a 3% fall or wake in oxygen saturation with at least a 
50% reduction in oral and nasal airflow for 10 s or more, 
while airflow stop for at least 10 s is defined as apnea. 
The rate obtained by dividing the sum of apnea and 
hypopnea counts seen in sleep by the hourly sleeping 
period is called the AHI.
Statistical analysis
Statistical analysis of the data was performed using SPSS 
17.0 software (SPSS Inc., Chicago, IL, USA). P < 0.05 
was considered to be statistically significant. All data 
are expressed as the mean ± standard deviation (SD). 
An independent‑sample t‑test was used to compare the 
parameters. Spearman’s correlation coefficient was used 
to examine the correlation between continuous variables.
Before the study, assuming that the difference between 
the two groups will have a medium effect size 
(Effect size Cohen d = 0,5), it is calculated that when 
100 participants (50 patients and 50 healthy control) 
were taken for the study 80% power can be obtained 
with 95% confidence.
When calculating for correlations, it is assumed 
that a moderate correlation would be obtained 
(Effect size |ρ| = 0,4), It was calculated that for the study 
group, 44 participants would be able to obtain 80% power 
with 95% confidence.
In our study, 44 patients and 47 healthy controls were 
taken. As a result of the power analysis performed by 
our own results, it is estimated that the power we have 
obtained is 99% with 95% confidence.
Results
A total of 44 patients with OSAS and a control group 
consisting of 47 people meeting these criteria were 
included. Table 1 shows the demographic characteristics 
and laboratory findings of the patients and control 
group. Compared with the control group, the patient 
groups showed significantly higher Hb values (P < 0.05) 
and lower mean corpuscular volume (MCV) (P < 0.05). 
Significant negative correlations were found between 
glucose levels and mean O2 saturation values in patients 
with severe OSAS (AHI >30) (r = −0.583, P = 0.02) 
[Figure 1].
Discussion
The hemoglobin levels in patients with OSAS were 
14.76 ± 1.72, which was significantly higher than 
in the control group. Feliciano et al. found that 
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hemoglobin levels were 15.3 ± 1.1 before treatment and 
14.9 ± 1 (P < 0.0001) after treatment in a hematological 
parameter study on OSAS patients.[8] Hemoglobin levels 
were elevated in OSAS and significantly decreased with 
treatment.[8] Erythropoietin levels increase in hypoxic 
conditions, and there is a tendency for polycythemia to 
occur.[9,10]
The red cell distribution width (RDW) is a part of the 
hemogram that provides information about the size of 
circulating erythrocytes and is routinely observed.[11,12] 
This parameter is calculated by dividing the SD of the 
erythrocyte volume by the MCV.[13] In recent studies, 
RDW has provided essential information for determining 
the prognosis in acute myocardial infarction, cardiac 
diseases such as stable coronary artery disease and heart 
failure,[14‑16] and noncardiac conditions such as stroke, 
pulmonary hypertension, and intensive care patients.[17‑19] 
The increase in RDW is attributed to inflammation in 
these diseases.[17‑19]
OSAS is also associated with hypoxia, increased 
oxidative stress,  and consequently increased 
inflammation.[20] For this reason, an increase in RDW is 
expected in OSAS. However, studies on OSAS suggest 
that RDW increases[11,12] or similar.[21] RDW increased in 
our study, although not significantly. RDW negatively 
correlates with MCV,[11] which can explain the decrease 
in MCV. In addition, four of the patients in our study had 
severe anemia. Accordingly, MCV may be low.
There was no significant difference between glucose 
levels and HbA1c levels between the OSAS group and 
control group. However, there was a negative correlation 
between mean O2 saturation values and glucose levels 
in severe OSAS. OSAS and type 2 diabetes mellitus are 
common comorbidities.[22] There is evidence supporting 
an independent association between OSAS and impaired 
glucose metabolism.[23] In a study with 1599 patients by 
Priou et al., the proportion of patients with AHI <5 and 
HbA1c >6% was 10.8%, while the proportion of patients 
with AHI ≥50 and HbA1c >6% was 34.2%.
[24] Similarly, 
in our study, there was a significant, independent 
association between decreases in saturation levels 
and HbA1c >6%.
[24] This disorder in OSAS and glucose 
metabolism is linked to intermittent hypoxia.[25]
The greatest limitation of our study is the limited number 
of cases. OSAS is associated with comorbid diseases such 
as heart failure, cardiovascular diseases, stroke, diabetes 
mellitus, hypertension, chronic obstructive pulmonary 
disease, and arrhythmia. Thus, the number of cases was 
reduced considerably since participants with any of these 
diseases and smokers were excluded from the study.
Conclusion
Even though significant differences were not found in 
the glucose and HbA1c levels of patients with OSAS, 
glucose metabolism was deteriorated when saturation 
was decreased in severe OSAS. Therefore, glucose levels 
should be observed frequently, particularly in severe 
cases of OSAS or in patients with hypoxia, regardless 
of the stage. More attention should also be paid to the 
development of diabetes.
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